发明名称 PROCESS TO MINIMIZE POLYMORPHISM
摘要 Disclosed is a process for preparing an oral, solid fast dispersing dosage form of a pharmaceutically active substance, wherein said substance exhibits polymorphism in an aqueous environment, comprising the steps of: (a) forming a suspension of particles of said substance in a carrier material in a continuous phase, wherein the carrier material comprises standard molecular weight fish gelatin; (b) reducing the suspension temperature to less than about 15ºC; (c) forming discrete units of the suspension at a formation temperature of less than about 15ºC; and (d) removing the continuous phase to leave the suspension of particles in the carrier material.
申请公布号 NZ587611(A) 申请公布日期 2012.07.27
申请号 NZ20090587611 申请日期 2009.02.26
申请人 R.P. SCHERER TECHNOLOGIES, LLC 发明人 HOWES, SIMON, A
分类号 A61K9/20;A61K9/06;A61K9/10;A61K31/551;A61K31/5517;A61K47/42;A61M36/14 主分类号 A61K9/20
代理机构 代理人
主权项
地址